Parallax Volatility Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Parallax Volatility Advisers’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.54M	Sell	50,000 -19,300	-28%	-$565K	﹤0.01%	847
2025 Q4	$2.01M	Buy	69,300 +54,300	+362%	+$1.63M	﹤0.01%	948
2025 Q3	$417K	Sell	15,000 -43,400	-74%	-$1.1M	﹤0.01%	1279
2025 Q2	$1.42M	Buy	+58,400	New	+$1.28M	﹤0.01%	980
2025 Q1	–	Sell	-6,700	Closed	-$158K	–	1556
2024 Q4	$158K	Sell	6,700 -50,300	-88%	-$1.24M	﹤0.01%	1697
2024 Q3	$1.46M	Hold	57,000	–	–	﹤0.01%	1238
2024 Q2	$1.34M	Buy	57,000 +7,000	+14%	+$177K	﹤0.01%	1164
2024 Q1	$1.44M	Hold	50,000	–	–	﹤0.01%	1128
2023 Q4	$1.64M	Hold	50,000	–	–	﹤0.01%	1230
2023 Q3	$1.39M	Hold	50,000	–	–	﹤0.01%	1235
2023 Q2	$1.7M	Hold	50,000	–	–	﹤0.01%	1200
2023 Q1	$1.5M	Buy	50,000 +48,700	+3,746%	+$1.51M	﹤0.01%	1335
2022 Q4	$36.7K	Sell	1,300 -7,500	-85%	-$238K	﹤0.01%	2406
2022 Q3	$289K	Sell	8,800 -187,200	-96%	-$6.87M	﹤0.01%	2190
2022 Q2	$6.17M	Sell	196,000 -252,200	-56%	-$8.82M	0.01%	898
2022 Q1	$20.6M	Buy	+448,200	New	+$21.4M	0.01%	494

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Parallax Volatility Advisers's ARKG Position: Q1 2026 in Review

Parallax Volatility Advisers reduced its ARK Genomic Revolution ETF (ARKG) stake by 9.5% in Q1 2026, selling an estimated $58.5K and leaving 19,071 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Parallax Volatility Advisers first reported a position in ARKG in Q1 2022 and has held it in 17 quarters since. The position peaked at $5.37M in Q2 2022. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Parallax Volatility Advisers held 19,071 shares of ARK Genomic Revolution ETF worth $586K as of Q1 2026.
Parallax Volatility Advisers sold 1,998 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $58.5K.
ARK Genomic Revolution ETF made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1035 holding.
Parallax Volatility Advisers first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 17 quarters since.
Parallax Volatility Advisers's ARK Genomic Revolution ETF position peaked at $5.37M in Q2 2022.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.